Compares treatment options for Social Anxiety Disorder (SAD)
Official title The Covideo Study - a Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delivery
ClinicalTrials.gov ID: NCT06901128
What this study is testing
- What it's testing
- The main goal of this clinical trial is to examine screen delivery as an alternative for offering cognitive therapy to youth with social anxiety. It will examine its effectiveness compared to office delivery, but also its acceptability and sustainability, and identify factors important for the outcome of this approach.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 18
You may be able to join if
- Social anxiety disorder primary
- Age 14 to 18 years.
- Norwegian fluency
You likely can't join if
- Severe Depression
- Acute suicidality
- Substance abuse
- Psychosis
- Intellectual Disability
- More than 20% absence from school in previous three months
The study team makes the final eligibility decision.
Where it's taking place
- Ottestad, Innlandet, Norway
- Førde, Norway
- Hamar, Norway
- Tromsø, Norway
- Trondheim, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ottestad, Innlandet, Norway; Førde, Norway; Hamar, Norway; Tromsø, Norway; Trondheim, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.